(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Crystal Gateway Marriott

2026 年 09 月 23 日 8:15 上午 - 2026 年 09 月 25 日 12:45 下午

1700 Richmond Highway, Arlington, VA 22202, USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

注册

亮点与特色

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

What is happening at DIA/FDA Oligonucleotide-Based Therapeutics Conference

  • Learn about the latest advancements, regulatory updates, and emerging trends in oligonucleotide therapies directly from leading industry experts and global regulators
  • Our three tracks (Clinical, Nonclinical, and CMC) will comprehensively cover a wide range of aspects of oligonucleotide therapeutics—from development to regulatory collaboration—and provide practical insights into current challenges and successful strategies for overcoming hurdles in clinical use, safety assessments, and CMC
  • This conference offers a networking opportunity to engage with peers, innovators, and regulators in sessions designed to foster meaningful collaboration and knowledge exchange


PDF Program

Preview all session descriptions, speakers, and more all in one place!

VIEW/PRINT
注册

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。